Latham & Watkins LLP‘s global antitrust and competition team houses a merger control offering which is experienced in complex mandates, handling a range of high profile litigation and intricate investigations. Its collaboration with teams in Brussels and London is particularly notable, leveraging cross-border strength to support clients with international filings. Global chair Michael G. Egge, working out of Washington DC, leveraged international experience in his representation of Bunge Limited in its $34bn merger with Viterra, triggering filings in over 40 jurisdictions. Also in DC, Amanda Reeves handles a range of merger clearance, antitrust litigation, and conduct investigations, while Lindsey Champlin has sector expertise spanning energy, automotives, advertising, and live entertainment. Champlin acts as Vice Chair for the group alongside Belinda Lee, in the Bay Area. The DC-based team additionally includes Ian Conner, who brings experience at the FTC and has notable expertise regarding healthcare sector matters. New York-based Katherine Rocco is a go-to for clients in the sports sector, and offers particular expertise in antitrust litigation, and in the Bay Area, Kelly Fayne regularly supports technology and media companies from deal inception through to merger litigation.
Legal 500 Editorial commentary
Accolades
Client satisfaction
Testimonials
Collated independently by Legal 500 research team.
- 'The Latham antitrust team is large and experienced, and can manage big projects with short deadlines.'
- 'Ian Conner is very good at what he does and is easy to work with.'
Key clients
- Bunge Limited
- Endeavor
- American Red Cross
- American Airlines
- US Sugar
- Everwatch
- Apollo
- Chesapeake Energy
- Grail
- Abbott Laboratories
Work highlights
- Advising Bunge Limited, a US grains merchant manufacturer, on the global merger control and FDI aspects for its merger with rival Viterra.
- Advised Equitrans Midstream through the US deal clearance process for their US$35 billion merger with EQT Corporation.
- Advised Cerevel Therapeutics, a biopharmaceutical company focused on developing new therapies to treat mood disorders, schizophrenia and Parkinson's disease, in its sale to AbbVie, a global biopharmaceutical company.
Lawyers
Hall of fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next generation partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Michael G. Egge; Belinda Lee; Lindsey Champlin
Other key lawyers
Katherine Rocco; Kelly Fayne; Ian Conner; Farrell J. Malone; Makan Delrahim; Jason Cruise; Amanda Reeves